ZBH Stock Analysis: Buy, Sell, or Hold?
ZBH - Zimmer Biomet Holdings, Inc.
$82.65
-0.07 (-0.08%)
▼
5d:
-0.86%
30d:
-12.26%
90d:
-13.16%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Smart Money Accumulation
ZBH is down 10.7% this week, but smart money is accumulating calls. Top strike: $95 2026-06-18 with 892 OI. Call ratio: 69% View Scanner →
Strength: 7.2/10
Get Alerted When ZBH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ZBH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ZBH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$119.92
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$74.46
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZBH is currently trading at $82.65, which is considered oversold relative to its 30-day fair value range of $82.79 to $94.13. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.2) compared to its historical average (10.4). Remarkably, the market is currently pricing in an annual earnings decline of 3.9% over the next few years. This pessimistic expectation contrasts with the company's recent 34.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ZBH is showing sideways momentum. Immediate support is located at $79.12, while resistance sits at $85.20.
Market Sentiment: ZBH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $98.52 (+19.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ZBH is showing sideways momentum. Immediate support is located at $79.12, while resistance sits at $85.20.
Market Sentiment: ZBH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $98.52 (+19.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$82.79 -
$94.13
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
Holding ZBH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($98.52)
Trading Range Analysis
30-Day Trading Range
$82.79 -
$94.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$79.12
Resistance Level
$85.20
Current Trend
Sideways
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.19
Wall Street Target
$98.52
(+19.2%)
Revenue Growth (YoY)
9.3%
Earnings Growth (YoY)
34.1%
Profit Margin
9.0%
Valuation Discount vs History
-3.9% cheaper
PE vs Historical
9.2 vs 10.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.9%
(market-implied from PE analysis)
1-Year Target
$79.43
(-4%)
2-Year Target
$76.33
(-8%)
3-Year Target
$73.35
(-11%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$83.00
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 6.2%)
$237.07
(+187%)
Base:
(SPY PE: 9.2, Growth: 6.2%)
$98.86
(+20%)
Bear:
(PE: 7.8, Growth: 6.2%)
$84.03
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 21.54 | Current EPS (TTM): $3.86
Bull Case
$182.89
(+121%)
Analyst growth 100.0%, PE expands to 23.7
Base Case
$166.26
(+101%)
Market implied 100.0%, PE stable at 21.5
Bear Case
$56.53
(-32%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.2 to 10.4
Stabilization Target:
$93.53
(+13.2%)
PE Expansion Potential:
+13.2%
Share & Embed Analysis
Last updated: May 14, 2026 6:32 PM ET
Data refreshes hourly during market hours. Next update: 7:32 PM
Data refreshes hourly during market hours. Next update: 7:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBH showing a specific setup today?
Insider Activity (6 Months)
5
Buys
4
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-23
Lori Winkler
SELL
2650 shares
2026-03-12
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |
Advanced ZBH Option Strategies
Professional options setups generated by AI based on today's ZBH price and gamma walls.
